Dergiler / Türk Onkoloji Dergisi / 2021 / Cilt: 36 - Sayı: 4

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma

Sayfa
438–445
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Hemogram parameters are found useful to predict disease properties and survival in EOC.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE The aim of the present study was to evaluate the impact of conventional hemogram parameters as a biomarker in epithelial ovarian cancer (EOC) patients; and the clinical importance of the difference after chemotherapy.
📊
Temel Bulgular & Veri:METHODS We have evaluated the patients with advanced-stage EOC who diagnosed between January 2012 and December 2017.
💡
Sonuç & Katkı:Hemogram parameters are found useful to predict disease properties and survival in EOC.
🔬Tür:Araştırma Makalesi
📍Kapsam:2012 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE The aim of the present study was to evaluate the impact of conventional hemogram parameters as a biomarker in epithelial ovarian cancer (EOC) patients; and the clinical importance of the difference after chemotherapy. METHODS We have evaluated the patients with advanced-stage EOC who diagnosed between January 2012 and December 2017. RESULTS Elevated levels of neutrophils, neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio at the time of diagnosis were significantly associated with excess amount of ascites. Lower levels of neutrophils and hemoglobin (HGB); and higher levels of red cell distribution width (RDW), and RDW/HGB ratio were predictors of platinum-sensitivity. In univariate analysis, while decreased mean platelet volume (MPV) was associated with longer disease free survival (DFS); elevated RDW, decreased neutrophils, MPV, and NLR were effective for better overall survival (OS). In multivariate analysis, platinum sensitivity and MPV were significantly associated with DFS and OS. Importantly, patients with persistently low MPV group after chemotherapy had the best OS; while persistently high MPV group had the worst OS. CONCLUSION MPV is a marker that can be easily evaluated during complete blood counts, and might be a promising and practical prognostic biomarker in the field of EOC. Hemogram parameters are found useful to predict disease properties and survival in EOC.

🔖

Bu Makaleye Atıf Yap

MİNARECİ, Y., TOPUZ, S., VATANSEVER, S., PAKSOY, N., BEKTAŞ, E., AK, N., FERHATOĞLU, F., AYDIN, E., DOĞAN, İ., KARACA, M., SOYDİNÇ, H. O., SÖZEN, H., SAİP, P. M. (2022). Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma. Türk Onkoloji Dergisi, Cilt: 36 - Sayı: 4, 438–445. https://ajindex.com/articles/639119

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends--an update. Cancer Epidemiol Biomarkers Prev 2016;25(1):16–27
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65(1):5–29
  3. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, et al. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of gynecologic oncology and american society of clinical oncology clinical practice guideline. Gynecol Oncol 2016;143(1):3–15
  4. Bhalla A, Zulfiqar M, Bluth MH. Molecular diagnostics in colorectal carcinoma: Advances and applications for 2018. Clin Lab Med 2018;38(2):311–42
  5. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287(1):G7–17
  6. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013;13(11):759–71
  7. Lalosevic J, Gajic-Veljic M, Bonaci-Nikolic B, Stojkovic Lalosevic M, Nikolic M. Combined intravenous pulse and topical corticosteroid therapy for severe alopecia areata in children: Comparison of two regimens. Dermatol Ther. 2019;32(6):e13092
  8. Li JY, Li Y, Jiang Z, Wang RT, Wang XS. Elevated mean platelet volume is associated with presence of colon cancer. Asian Pac J Cancer Prev 2014;15(23):10501–4
  9. Kemal Y, Demirag G, Ekiz K, Yucel I. Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer. J Obstet Gynaecol 2014;34(6):515–8. 10.Sahin ZA, Toktas IU, Toraman C, Yuksel IT, Seyhan A, Akbayir O. Clinical and prognostic value of pre-operative systemic inflammatory markers in clinical course and prognosis of ovarian cancer. Eur J Gynaecol Oncol 2020;41(6):924–30. 11.Soonthornthum T, Suraseraneewong V, Kengsakol K, Wijaithum K, Kasemsan P, Prommatt S. Thrombocytosis in advanced epithelial ovarian cancer. J Med Assoc Thai 2007;90(8):1495–500. 12.Canzler U, Lück HJ, Neuser P, Sehouli J, Burges A, Harter P, et al. Prognostic role of thrombocytosis in recurrent ovarian cancer: A pooled analysis of the AGO study group. Arch Gynecol Obstet 2020;301(5):1267– 74. 13.Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009;58(1